Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres

Anna Florczak,1,2 Andrzej Mackiewicz,1,2 Hanna Dams-Kozlowska1,21Department of Medical Biotechnology, Poznan University of Medical Sciences, Poznan 60-806, Poland; 2Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan 61-866, PolandCorrespondence: Hanna Dams-Kozlowsk...

Full description

Bibliographic Details
Main Authors: Florczak A, Mackiewicz A, Dams-Kozlowska H
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/cellular-uptake-intracellular-distribution-and-degradation-of-her2-tar-peer-reviewed-article-IJN
id doaj-e9ac98b4a13b40a1a975d0f06c74283e
record_format Article
spelling doaj-e9ac98b4a13b40a1a975d0f06c74283e2020-11-25T01:43:54ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-08-01Volume 146855686548120Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheresFlorczak AMackiewicz ADams-Kozlowska HAnna Florczak,1,2 Andrzej Mackiewicz,1,2 Hanna Dams-Kozlowska1,21Department of Medical Biotechnology, Poznan University of Medical Sciences, Poznan 60-806, Poland; 2Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan 61-866, PolandCorrespondence: Hanna Dams-KozlowskaDepartment of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 15 Garbary St., Poznan 61-866, PolandTel +48 61 885 0874Fax +48 61 852 8502Email hanna.dams-kozlowska@wco.plBackground: The development of nanocarrier technology has attracted great interest in the last decade. Biodegradable spheres made of functionalized silk have considerable potential to be used as drug delivery systems for cancer treatment. A targeting ligand displayed at the surface of a carrier, with a specific affinity towards a particular receptor, can further enhance the accumulation and uptake of nanoparticles at the site of a tumor.Materials and methods: The hybrid constructs were obtained by adding a Her2-binding peptide (H2.1) to MS1 and MS2 bioengineered silks based on the MaSp1 and MaSp2 proteins from N. clavipes, respectively. The H2.1MS1 and H2.1MS2 proteins were blended at a weight ratio of 8:2. Stable silk particles were formed by mixing a soluble protein with potassium phosphate using a micromixing technique. We used specific inhibitors of endocytosis to determine the cellular uptake pathway of the silk nanoparticles in human Her2-positive breast cancer cells. The subcellular distribution of silk particles was investigated by evaluating the signal colocalization with organelle-specific tracker. Moreover, lysosomal and exosomal inhibitors were implemented to evaluate their impact on the silk spheres behavior and degradation.Results: The functionalized spheres were specifically taken up by Her2-positive cancer cells. Silk particles facilitated the entry into cells through both the clathrin- and caveola-dependent pathways of endocytosis. Upon entering the cells, the particles accumulated in the lysosomes, where intracellular degradation occurred.Conclusions: The present study demonstrated directly that the lysosomal function was essential for silk-based carrier elimination. The degradation of the carrier is of great importance to develop an optimal drug delivery system.Keywords: silk spheres, endocytosis, nanoparticle trafficking, lysosomal degradation, targeted drug delivery, cancer therapyhttps://www.dovepress.com/cellular-uptake-intracellular-distribution-and-degradation-of-her2-tar-peer-reviewed-article-IJNsilk spheresendocytosisnanoparticle traffickinglysosomal degradationtargeted drug deliverycancer therapy
collection DOAJ
language English
format Article
sources DOAJ
author Florczak A
Mackiewicz A
Dams-Kozlowska H
spellingShingle Florczak A
Mackiewicz A
Dams-Kozlowska H
Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
International Journal of Nanomedicine
silk spheres
endocytosis
nanoparticle trafficking
lysosomal degradation
targeted drug delivery
cancer therapy
author_facet Florczak A
Mackiewicz A
Dams-Kozlowska H
author_sort Florczak A
title Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
title_short Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
title_full Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
title_fullStr Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
title_full_unstemmed Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres
title_sort cellular uptake, intracellular distribution and degradation of her2-targeting silk nanospheres
publisher Dove Medical Press
series International Journal of Nanomedicine
issn 1178-2013
publishDate 2019-08-01
description Anna Florczak,1,2 Andrzej Mackiewicz,1,2 Hanna Dams-Kozlowska1,21Department of Medical Biotechnology, Poznan University of Medical Sciences, Poznan 60-806, Poland; 2Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan 61-866, PolandCorrespondence: Hanna Dams-KozlowskaDepartment of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 15 Garbary St., Poznan 61-866, PolandTel +48 61 885 0874Fax +48 61 852 8502Email hanna.dams-kozlowska@wco.plBackground: The development of nanocarrier technology has attracted great interest in the last decade. Biodegradable spheres made of functionalized silk have considerable potential to be used as drug delivery systems for cancer treatment. A targeting ligand displayed at the surface of a carrier, with a specific affinity towards a particular receptor, can further enhance the accumulation and uptake of nanoparticles at the site of a tumor.Materials and methods: The hybrid constructs were obtained by adding a Her2-binding peptide (H2.1) to MS1 and MS2 bioengineered silks based on the MaSp1 and MaSp2 proteins from N. clavipes, respectively. The H2.1MS1 and H2.1MS2 proteins were blended at a weight ratio of 8:2. Stable silk particles were formed by mixing a soluble protein with potassium phosphate using a micromixing technique. We used specific inhibitors of endocytosis to determine the cellular uptake pathway of the silk nanoparticles in human Her2-positive breast cancer cells. The subcellular distribution of silk particles was investigated by evaluating the signal colocalization with organelle-specific tracker. Moreover, lysosomal and exosomal inhibitors were implemented to evaluate their impact on the silk spheres behavior and degradation.Results: The functionalized spheres were specifically taken up by Her2-positive cancer cells. Silk particles facilitated the entry into cells through both the clathrin- and caveola-dependent pathways of endocytosis. Upon entering the cells, the particles accumulated in the lysosomes, where intracellular degradation occurred.Conclusions: The present study demonstrated directly that the lysosomal function was essential for silk-based carrier elimination. The degradation of the carrier is of great importance to develop an optimal drug delivery system.Keywords: silk spheres, endocytosis, nanoparticle trafficking, lysosomal degradation, targeted drug delivery, cancer therapy
topic silk spheres
endocytosis
nanoparticle trafficking
lysosomal degradation
targeted drug delivery
cancer therapy
url https://www.dovepress.com/cellular-uptake-intracellular-distribution-and-degradation-of-her2-tar-peer-reviewed-article-IJN
work_keys_str_mv AT florczaka cellularuptakeintracellulardistributionanddegradationofher2targetingsilknanospheres
AT mackiewicza cellularuptakeintracellulardistributionanddegradationofher2targetingsilknanospheres
AT damskozlowskah cellularuptakeintracellulardistributionanddegradationofher2targetingsilknanospheres
_version_ 1725030866104614912